Activity value 76india Supplier,Last transaction date:
2026-05-01
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for medex pharmaceuticals from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 56 transactions, with a transaction quantity of 9578 and a transaction weight of 0.
Product description
MEDICAMENTS CONTAINING HORMONES OR STEROIDS USED AS HORMONES BUT NOT ANTIBIOTICS, PUT UP IN MEASURED DOSES INCL. THOSE FOR TRANSDERMAL ADMINISTRATION OR IN FORMS OR PACKINGS FOR RETAIL SALE (EXCL. MEDICAMENTS CONTAINING INSULIN OR CORTICOSTEROID HORMONES, THEIR DERIVATIVES OR STRUCTURAL ANALOGUES)
Expand
Product description
MEDICAMENTS CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC PURPOSES, PUT UP IN MEASURED DOSES INCL. THOSE FOR TRANSDERMAL ADMINISTRATION OR IN FORMS OR PACKINGS FOR RETAIL SALE (EXCL. CONTAINING ANTIBIOTICS, HORMONES OR STEROIDS USED AS HORMONES, ALKALOIDS, PROVITAMINS, VITAMINS, THEIR DERIVATIVES, ANTIMALARIAL ACTIVE PRINCIPLES AND BLINDED CLINICAL TRIAL KITS)
Expand
Product description
MEDICAMENTS CONTAINING HORMONES OR STEROIDS USED AS HORMONES BUT NOT ANTIBIOTICS, PUT UP IN MEASURED DOSES INCL. THOSE FOR TRANSDERMAL ADMINISTRATION OR IN FORMS OR PACKINGS FOR RETAIL SALE (EXCL. MEDICAMENTS CONTAINING INSULIN OR CORTICOSTEROID HORMONES, THEIR DERIVATIVES OR STRUCTURAL ANALOGUES)
Expand
Product description
MEDICAMENTS CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC PURPOSES, PUT UP IN MEASURED DOSES INCL. THOSE FOR TRANSDERMAL ADMINISTRATION OR IN FORMS OR PACKINGS FOR RETAIL SALE (EXCL. CONTAINING ANTIBIOTICS, HORMONES OR STEROIDS USED AS HORMONES, ALKALOIDS, PROVITAMINS, VITAMINS, THEIR DERIVATIVES, ANTIMALARIAL ACTIVE PRINCIPLES AND BLINDED CLINICAL TRIAL KITS)
Expand
Trade date
2026/02/25
B/L No.
3518214
Suppliers
medex pharmaceuticals
Buyers
schering drug stores llc
POLs
mumbai (ex bombay)
PODs
dubai
Supply area
India
Purchas area
United Arab Emirates
medex pharmaceuticals is india Supplier,
and primarily engages in the import and export business of products such as bat,hydrochloride,data logger.
According to the 52wmb.com global trade database, as of 2026-05-01, the company has completed 2286 international trades,
with its main trading regions covering united arab emirates,lebanon etc.
The core products include HS30049099,HS30049049,HS90251990 etc,
often transported via bombay air,port sahar air, port chennai etc,
and its main trading partners are best international / fze,medisuite medical store house llc,schering drug stores llc.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on medex pharmaceuticals is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.